Aline Charabaty, MD, FACG

Johns Hopkins University School of Medicine

Poster(s):

• P3240 - Mirikizumab Demonstrates Durable and Sustained Maintenance of Endoscopic and Histologic Outcomes at 4 Years in Patients With Moderately-to-Severely Active Ulcerative Colitis: LUCENT-3 Open-Label Extension Study
  Monday, October 27, 2025

  10:30 AM - 4:00 PM PDT

• P3241 - Patient-Reported Use of Concomitant Treatments for Crohn’s Disease Among Adults Treated With Risankizumab in Clinical Practice: Initial Results From the ASPIRE-CD Study
  Monday, October 27, 2025

  10:30 AM - 4:00 PM PDT